Detectable viral load aggravates immunosenescence features of CD8 T-cell subsets in vertically HIV-infected children

Journal of Acquired Immune Deficiency Syndromes

Volumn 60, Issue 5, 2012, Pages 447-454

  Díaz, Laura ^a   Méndez Lagares, Gema ^b   Correa Rocha, Rafael ^a   Pacheco, Yolanda María ^b   Ferrando Martínez, Sara ^a   Ruiz Mateos, Ezequiel ^b   Pozo Balado, María Del Mar Del ^c   León, Juan Antonio ^b   Gurbindo, María Dolores ^d   Isabel De José, María ^e   Leal, Manuel ^b   Muñoz Fernández, M Ángeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c Instituto de Biomedicina de Sevilla   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

CD8+ T cells; HIV; immunosenescence; vertical HIV infected children; viral load

Indexed keywords

ADOLESCENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL AGING; CELL PROLIFERATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MULTICENTER STUDY; PHENOTYPE; PREMATURE AGING; PRIORITY JOURNAL; SCHOOL CHILD; VIREMIA; VIRUS LOAD;

ADOLESCENT; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; VIRAL LOAD;

EID: 84864282604     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318259254f     Document Type: Article

References (49)

1. Fortuny C, Noguera-Julian A, Alsina L, et al. Impact of CD4 T cell count on the outcome of planned treatment interruptions in early-treated human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2011;30: 435-438.
2. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458-465.
3. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among hiv-infected infants. N Engl J Med. 2008;359: 2233-2244.
4. Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 2003;17:1881-1888. (Pubitemid 37070273)
5. Lori F. Treating HIV/AIDS by reducing immune system activation: the paradox of immune deficiency and immune hyperactivation. Curr Opin HIV AIDS. 2008;3:99-103. (Pubitemid 351322820)
6. Papagno L, Spina CA, Marchant A, et al. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2004;2:E20.
7. Appay V, Almeida JR, Sauce D, et al. Accelerated immune senescence and HIV-1 infection. Exp Gerontol. 2007;42:432-437. (Pubitemid 46561182)
8. McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol. 2009;21:418-424.
9. van Baarle D, Tsegaye A, Miedema F, et al. Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system. Immunol Lett. 2005;97:19-29. (Pubitemid 40038851)
10. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711-2720. (Pubitemid 36857634)
11. Effros RB. The role of CD8 T cell replicative senescence in human aging. Discov Med. 2005;5:293-297.
12. Appay V, Zaunders JJ, Papagno L, et al. Characterization of CD4(+) CTLs ex vivo. J Immunol. 2002;168:5954-5958.
13. Shin H, Wherry EJ. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol. 2007;19:408-415. (Pubitemid 47284857)
14. Appay V, Papagno L, Spina CA, et al. Dynamics of T cell responses in HIV infection. J Immunol. 2002;168:3660-3666. (Pubitemid 34250438)
15. Roederer M, Dubs JG, Anderson MT, et al. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest. 1995;95: 2061-2066.
16. Bestilny LJ, Gill MJ, Mody CH, et al. Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS. 2000; 14:771-780. (Pubitemid 30303453)
17. Pantaleo G, Soudeyns H, Demarest JF, et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci USA. 1997;94:9848-9853.
18. Correa R, Harari A, Vallelian F, et al. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure. AIDS. 2007;21:23-30. (Pubitemid 44912533)
19. Shalekoff S, Meddows-Taylor S, Gray GE, et al. Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers. AIDS. 2009;23:789-798.
20. Cao W, Jamieson BD, Hultin LE, et al. Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr. 2009;50:137-147.
21. Desai S, Landay A. Early immune senescence in HIV disease. Curr HIV/AIDS Rep. 2010;7:4-10.
22. Zeichner SL, Palumbo P, Feng Y, et al. Rapid telomere shortening in children. Blood. 1999;93:2824-2830. (Pubitemid 29200772)
23. Mansoor N, Abel B, Scriba TJ, et al. Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. Clin Immunol. 2009;130:280-289.
24. Barnhart HX, Caldwell MB, Thomas P, et al. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. Pediatrics. 1996;97: 710-716. (Pubitemid 26138104)
25. Garcia-Merino I, de Las Cuevas N, Jimenez JL, et al. The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology. 2009;6:27.
26. Ferrando-Martinez S, Ruiz-Mateos E, Leal M. CD27 and CCR7 expression on naive T cells, are both necessary? Immunol Lett. 2010;127: 157-158.
27. Slyker JA, John-Stewart GC, Dong T, et al. Phenotypic characterization of HIV-specific CD8 T cells during early and chronic infant HIV-1 infection. PLoS One. 2011;6:e20375.
28. Lohman BL, Slyker JA, Richardson BA, et al. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J Virol. 2005;79:8121-8130. (Pubitemid 40853515)
29. Huang S, Dunkley-Thompson J, Tang Y, et al. Deficiency of HIVgag-specific T cells in early childhood correlates with poor viral containment. J Immunol. 2008;181:8103-8111.
30. Scott-Algara D, Buseyne F, Blanche S, et al. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIVinfected children, using major histocompatibility complex class I peptide tetramers. J Infect Dis. 2001;183:1565-1573. (Pubitemid 32466693)
31. Le Priol Y, Puthier D, Lecureuil C, et al. High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals. J Immunol. 2006;177:5145-5154. (Pubitemid 44527586)
32. Resino S, Correa R, Bellon JM, et al. Preserved immune system in longterm asymptomatic vertically HIV-1 infected children. Clin Exp Immunol. 2003;132:105-112. (Pubitemid 36422601)
33. Resino S, Sanchez-Ramon S, Correa R, et al. Complete immune and clinical recovery after highly active antiretroviral therapy in advanced vertically HIV-1 infected childrenin Spanish. Med Clin (Barc). 2003; 120:417-420. (Pubitemid 36511881)
34. Lee KJ, Shingadia D, Pillay D, et al. Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean? Antivir Ther. 2007;12:949-956. (Pubitemid 47492564)
35. Rabin RL, Roederer M, Maldonado Y, et al. Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. J Clin Invest. 1995;95:2054-2060.
36. Zanni F, Vescovini R, Biasini C, et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol. 2003;38:981-987. (Pubitemid 37045361)
37. Murray JM, Kaufmann GR, Hodgkin PD, et al. Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty. Immunol Cell Biol. 2003;81:487-495. (Pubitemid 38402310)
38. Correa R, Munoz-Fernandez MA. Viral phenotype affects the thymic production of new T cells in HIV-1-infected children. AIDS. 2001;15: 1959-1963. (Pubitemid 32980637)
39. Correa R, Munoz-Fernandez A. Effects of highly active antiretroviral therapy on thymical reconstitution of CD4 T lymphocytes in vertically HIV-infected children. AIDS. 2002;16:1181-1183. (Pubitemid 34533858)
40. Correa R, Munoz-Fernandez MA. Production of new T cells by thymus in children: effect of HIV infection and antiretroviral therapy. Pediatr Res. 2002;52:207-212. (Pubitemid 34827240)
41. Montesano C, Anselmi A, Palma P, et al. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children. New Microbiol. 2010;33:303-309.
42. Resino S, Seoane E, Perez A, et al. Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy. BMC Infect Dis. 2006;6:112.
43. Dunne PJ, Faint JM, Gudgeon NH, et al. Epstein-Barr virus-specific CD8 (+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood. 2002;100:933-940. (Pubitemid 34832620)
44. Northfield JW, Loo CP, Barbour JD, et al. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. J Virol. 2007;81:5759-5765. (Pubitemid 46847014)
45. Jordan KA, Furlan SN, Gonzalez VD, et al. CD8 T cell effector maturation in HIV-1-infected children. Virology. 2006;347:117-126.
46. Chun TW, Justement JS, Murray D, et al. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS. 2010;24: 2803-2808.
47. Chun TW, Nickle DC, Justement JS, et al. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J Clin Invest. 2005;115: 3250-3255. (Pubitemid 41567589)
48. Yamamoto T, Price DA, Casazza JP, et al. Surface expression patterns of negative regulatory molecules identify determinants of virusspecific CD8+ T-cell exhaustion in HIV infection. Blood. 2011;117: 4805-4815.
49. Koch S, Larbi A, Derhovanessian E, et al. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing. 2008;5:6.